- Home
- OTLK vs OST Comparison
OTLK vs OST Comparison
Compare OTLK & OST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTLK
- OST
- Stock Information
- Founded
- OTLK 2010
- OST 2010
- Country
- OTLK United States
- OST China
- Employees
- OTLK N/A
- OST N/A
- Industry
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- OST Industrial Machinery/Components
- Sector
- OTLK Health Care
- OST Technology
- Exchange
- OTLK Nasdaq
- OST Nasdaq
- Market Cap
- OTLK 48.3M
- OST 51.0M
- IPO Year
- OTLK 2016
- OST 2022
- Fundamental
- Price
- OTLK $1.77
- OST $5.72
- Analyst Decision
- OTLK Strong Buy
- OST
- Analyst Count
- OTLK 5
- OST 0
- Target Price
- OTLK $10.20
- OST N/A
- AVG Volume (30 Days)
- OTLK 689.4K
- OST 1.9M
- Earning Date
- OTLK 05-15-2025
- OST 01-27-2025
- Dividend Yield
- OTLK N/A
- OST N/A
- EPS Growth
- OTLK N/A
- OST N/A
- EPS
- OTLK 0.83
- OST N/A
- Revenue
- OTLK N/A
- OST $32,463,213.00
- Revenue This Year
- OTLK N/A
- OST N/A
- Revenue Next Year
- OTLK $288.46
- OST N/A
- P/E Ratio
- OTLK $2.12
- OST N/A
- Revenue Growth
- OTLK N/A
- OST N/A
- 52 Week Low
- OTLK $0.87
- OST $0.78
- 52 Week High
- OTLK $9.25
- OST $5.72
- Technical
- Relative Strength Index (RSI)
- OTLK 57.64
- OST 81.09
- Support Level
- OTLK $1.55
- OST $4.00
- Resistance Level
- OTLK $1.90
- OST $4.84
- Average True Range (ATR)
- OTLK 0.18
- OST 0.31
- MACD
- OTLK 0.01
- OST 0.04
- Stochastic Oscillator
- OTLK 53.10
- OST 100.00
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About OST Ostin Technology Group Co. Ltd.
Ostin Technology Group Co Ltd is a supplier of display modules and polarizers in China. It designs, develops, and manufactures TFT-LCD modules in a wide range of sizes and customized sizes according to the specifications of its customers. Its display modules are mainly used in consumer electronics, commercial LCD displays, and automotive displays. The company also manufactures polarizers used in the TFT-LCD display modules and is in the process of developing polarizers for the OLED display panel. Geographically, the company generates revenue from Hong Kong, Taiwan, and Mainland China which is its key revenue generating market.